Loading
Total declarations
Company
▲ Purchases (20 ops.)
▼ Sales (29 ops.)
Latest filing published 18 Aug 2026 for BRUKER CORP.
Filing timeline
BuySaleFrank H. Laukien
Insider track record
Disclosed buys
20
Disclosed sells
29
Signal history
Closed purchases
Market purchases
20
Positive at T+90
63%
Median T+90
+3.8%
Based on 19 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +35.1%Entry US$40.66 · Close at T+365 US$54.92
- -27.7%Entry US$52.92 · Close at T+365 US$38.28
- -17.9%Entry US$53.37 · Close at T+365 US$43.84
- +21.3%Entry US$61.23 · Close at T+365 US$74.26
- +72.2%Entry US$39.81 · Close at T+365 US$68.55
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Frank H. Laukien: trading record in brief
Frank H. Laukien, PRESIDENT & CEO of Bruker Corp, filed 19 purchases worth EUR 8,360,053 in total (median EUR 93,146) and 29 sales worth EUR 96.2 million (median EUR 2,061,096), so purchases are 40% of market trades. The largest purchases: EUR 3,304,356 and EUR 1,280,952 on November 18, 2024, EUR 889,341 on May 17, 2017. The largest sales: EUR 14,753,275 on June 3, 2019, EUR 11,680,832 on May 29, 2019 and EUR 10,703,326 on April 24, 2023.
Of the 19 purchases with a stored 90-day result, the median is 3.8% and 63% are positive: stored past results, not a forecast.
The record holds 101 filings, with 39 share grants, 12 option exercises and 2 filings of another kind. The busiest year is 2023, with 31 filings, far ahead of 2022 (11). Five filings fall in the last twelve months, with no market trade.
At Bruker, Marc A. Kastner has 25 trades within 30 days of Laukien's, in the same direction; Richard A. Packer has 4 (1 in the same direction) and Thomas Bures 2.
Companies and markets linked to Frank H. Laukien
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations101 total
29,463 shares0Common StockSEC:0001133649-26-000005:0
4,760 shares@ US$57.700.5% of flowCommon StockSEC:0001133649-26-000005:1
4,838 shares@ US$57.020.5% of flowCommon StockSEC:0001133649-26-000003:0
2,361 shares@ US$53.410.2% of flowCommon StockSEC:0001133649-26-000002:0
4,564 shares@ US$56.320.5% of flowCommon StockSEC:0001133649-26-000002:1
48,431 shares0Common StockSEC:0001415889-25-022299:0
3,422 shares@ US$30.430.2% of flowCommon StockSEC:0001415889-25-021492:0
4,657 shares@ US$30.430.3% of flowCommon StockSEC:0001415889-25-021492:1
4,838 shares@ US$30.780.3% of flowCommon StockSEC:0001415889-25-021492:2
3,582 shares@ US$32.070.2% of flowCommon StockSEC:0001415889-25-021251:0
2,608 shares@ US$38.360.2% of flowCommon StockSEC:0001415889-25-016232:0
Canonical exit: 4 Sept 2025 (T+90)
6,937 shares@ US$51.230.3% of flowCommon StockSEC:0001415889-25-004613:1
Canonical exit: 19 May 2025 (T+90)
13,063 shares@ US$50.751.4% of flowCommon StockSEC:0001415889-25-004613:0
Canonical exit: 19 May 2025 (T+90)
26,551 shares@ US$50.821.0% of flowCommon StockSEC:0001415889-24-027187:1
Canonical exit: 16 Feb 2025 (T+90)
3,583 shares@ US$51.360.1% of flowCommon StockSEC:0001415889-24-027187:2
Canonical exit: 16 Feb 2025 (T+90)
69,866 shares@ US$49.827.1% of flowCommon StockSEC:0001415889-24-027187:0
Canonical exit: 16 Feb 2025 (T+90)
28,307 shares0Common StockSEC:0001415889-24-021180:0
4,657 shares@ US$60.420.6% of flowCommon StockSEC:0001415889-24-021180:1
4,838 shares@ US$60.420.6% of flowCommon StockSEC:0001415889-24-021180:2
3,582 shares@ US$63.540.4% of flowCommon StockSEC:0001415889-24-020896:0
2,174 shares@ US$62.160.1% of flowCommon StockSEC:0001415889-24-020896:1
1,404 shares@ US$73.360.2% of flowCommon StockSEC:0001415889-24-007626:0
57,356 shares@ US$46.152.0% of flowCommon StockSEC:0001415889-23-014591:1
2,167 shares@ US$46.1450.2% of flowCommon StockSEC:0001415889-23-014591:0
4,421 shares@ US$66.960.2% of flowCommon StockSEC:0001415889-23-012217:1
25 of 101 declarations
